Marcia Cross wants to end the shame surrounding anal cancer.
The"Desperate Housewives" star appeared on Wednesday's episode of"CBS This Morning" to discuss her diagnosis more than a year ago.More than 1 in 5 adults has cancer-causing HPV, CDC reportsCross, 57, said it came about as a result of a routine digital rectum exam during a visit to her gynecologist.
Should you then also feel like ashamed like you did something bad because it took up residence in your anus?"Her husband, actor Tom Mahoney, was diagnosed with throat cancer in 2009.Doctors now suspect that Cross' cancer and Mahoney's came from the same type of human papillomavirus, known as HPV.HPV can be transferred through sexual intercourse or skin-to-skin contact and can also cause cancer of the cervix and genitals.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Marcia Cross says HPV may have caused cancer for her and her husband
Read more »
Man killed in alleged shootout with officers at US-Mexico port of entry: PoliceA U.S. citizen was shot and killed after he sped through an inspection checkpoint while allegedly attempting to cross into the United States at the San Diego-Tijuana, Mexico border, and then opened fire on officers, according to San Diego police.
Read more »
Uber analysts ride dreams to common destinationThey expect the $70 bln ride-hailing app to lose money for years but see various grounds for optimism, from cross-platform synergies to flying cars to demographics. Yet most roads lead to a forecast price upside of around 25%. It’s Wall Street’s form of herd immunity.
Read more »
Marcia Cross says HPV may have caused cancer for her and her husband
Read more »
U.S. man killed during gunbattle with border officers at California crossing, officials sayA U.S. man who failed to stop for an inspection while entering the U.S. at the California-Mexico border was shot and killed during a gunbattle with border officers, San Diego police said.
Read more »
We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billionMerck is testing the treatment, called Keytruda, in more types of cancer and in combination with other therapies.
Read more »